Recruiting

Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD

Sponsor:

Washington D.C. Veterans Affairs Medical Center

Code:

NCT06110130

Conditions

Chronic Kidney Diseases

Eligibility Criteria

Sex: All

Age: 19 - 70+

Healthy Volunteers: Not accepted

Interventions

Empagliflozin 10 MG

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information